(SAN DIEGO and ADELAIDE January 26,2022) BioCina, a leading contract development and manufacturing organization (CDMO) announces the appointment of Rick Hancock, Chairman of the Board. Hancock, with over 35 years of experience in life sciences, has held various board, executive and operational positions, developing expertise in cGMP manufacturing including plasmids, regulatory affairs, R & D, and operational […]
PR Release – BioCina awarded Grant to advance RNA vaccines and therapeutics
/in News(SAN DIEGO and ADELAIDE April 5, 2022) BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a $3.0m AUD grant under the Federal Government’s Cooperative Research Centres Projects (CRC-P) Grants scheme to fund work with its industry partners to further develop RNA vaccines and therapeutics. The grant has […]
Behind the doors of the bacterial factory
/in BlogPublished in Cosmos Magazine By Ellen Phiddian Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. BioCina’s pharmaceutical manufacturing plant, in Adelaide, is Australia’s only internationally certified microbial fermentation operation – and a lesson in keeping it clean. So how do they do it? Cosmos […]
Home-grown mRNA: inside the Adelaide facility that can make it
/in BlogPublished in Cosmos Magazine Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. Cosmos takes a look at BioCina’s pharmaceutical manufacturing process. While Moderna has announced it will be making mRNA vaccines on Australian shores by 2024, there are places that could already be doing parts of […]
PR Release – Rick Hancock named as Board Chairman for BioCina
/in News(SAN DIEGO and ADELAIDE January 26,2022) BioCina, a leading contract development and manufacturing organization (CDMO) announces the appointment of Rick Hancock, Chairman of the Board. Hancock, with over 35 years of experience in life sciences, has held various board, executive and operational positions, developing expertise in cGMP manufacturing including plasmids, regulatory affairs, R & D, and operational […]
PR Release – BioCina expands expertise of Board of Directors with new member Sven Lee
/in News(San Diego, June 30, 2021) BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics announces today the appointment of Sven Lee to the Board of Directors. BioCina is recognized for delivering high-quality, cost effective microbial process development and manufacturing solutions, leveraging a team of multi-disciplinary […]
PR Release – BioCina officially opens full-service CDMO in Adelaide, Australia, including mRNA and pDNA cGMP manufacturing
/in News(SAN DIEGO and ADELAIDE, November 30, 2021) BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the official opening of its new biologics manufacturing facility in Adelaide, Australia. The official opening for the research, development and manufacturing biologic plant in Adelaide […]
PR Release – BioCina expands into full-service CDMO with full control of Pfizer manufacturing facility in Adelaide, Australia
/in News(SAN DIEGO and ADELAIDE, October 5, 2021) BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the full and final transition from Hospira Adelaide Pty Ltd., an affiliate of Pfizer Inc., of its biologics manufacturing facility, colleagues and operations in Adelaide, Australia. This completes […]
South Australian mRNA vaccines?
/in BlogJuly 5, 2021 Published in Cosmos Magazine Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. “Last month, the federal government closed applications for a critical approach to market process: it was looking for biotech firms that want to make messenger RNA (mRNA) vaccines in Australia. The […]
SA ‘well-heeled’ to manufacture advanced COVID vaccines
/in BlogJuly 5, 2021 Published in InDaily Excerpts copied below. Read the full article in InDaily at the link at the bottom of the page. “A push to manufacture advanced mRNA coronavirus vaccines at a plant in Thebarton remains on track as biotech and research consortiums across Australia look to answer the Federal Government’s call to […]
SA in vaccine manufacturing race
/in BlogMay 14, 2021 Published in InDaily Excerpts copied below. Read the full article in InDaily at the link at the bottom of the page. “The race to secure COVID-19 vaccine manufacturing in South Australia is heating up as the federal government prepares to make an approach to market for a local mRNA manufacturing plant in […]